Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis

Kang MJ, Kim MS, Choi EH, Lee KE, Kim YK, Choi HJ

Inhibitors of tumor necrosis factor-alpha (TNF-alpha) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pseudomembranous Colitis in a Juvenile Rheumatoid Arthritis Patient Taking Methotrexate

Yu J, Kim NY, Lee HM, Lee HN, Ahn HJ, Kim SW, Choi KY

Pseudomembranous colitis is mainly caused by antibiotics and Clostridium difficile infection. But conditions such as gastrointestinal surgery, antacid medication, anti-neoplastic agent or immunosuppressive agent which influences the normal flora of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Tuberculous Arthritis Following the Use of Etanercept

Choi SW, Ahn JJ, Hwang YT, Koh SH, Cho SD

Etanercept is a tumor necrosis factor (TNF) inhibitor that has been used for the treatment of chronic inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Because of its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Etanercept-Induced Systemic Lupus Erythematosus in a Patient with Rheumatoid Arthritis

Kang MJ, Lee YH, Lee J

Tumor necrosis factor (TNF) is known to play a critical role in the pathogenesis of rheumatoid arthritis (RA). Etanercept is a recombinant soluble fusion protein of TNF type II receptor...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr